NCT07189117 Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies
| NCT ID | NCT07189117 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Hematologic Malignancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2025-10-29 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2025-10-29 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates how metabolism in cancer and immune cells shapes the bone marrow environment, influences therapy resistance, and affects outcomes in hematological malignancies.
Eligibility Criteria
Inclusion Criteria: * age \> 18 years, * signed written informed consent * For participants with hematological cancers: diagnosis of MDS, AML, ALL, PMF or post-ET/PV MF Exclusion Criteria: * pregnant or lactating women, * inability to give consent, * active malignant disease (other than MDS, AML, ALL, PMF or post-ET/PV MF in the last 3 - years prior to study inclusion). * For healthy donors: previous or current hematological disease, previous or current other malignant disease,
Contact & Investigator
Petya Apostolova, Prof. Dr.
STUDY CHAIR
University Hospital of Basel
Frequently Asked Questions
Who can join the NCT07189117 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematologic Malignancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07189117 currently recruiting?
Yes, NCT07189117 is actively recruiting participants. Contact the research team at petya.apostolova@unibas.ch for enrollment information.
Where is the NCT07189117 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT07189117 clinical trial?
NCT07189117 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Petya Apostolova, Prof. Dr. at University Hospital of Basel. The trial plans to enroll 350 participants.